Long-Term Assets: The sum of all assets classified as non-current.
Intellia Therapeutics, Inc. (NTLA) had Long-Term Assets of $434.77M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$16.63M |
|
$-114.33M |
|
-- |
|
$16.63M |
|
$137.43M |
|
$-120.81M |
|
$6.48M |
|
$-114.33M |
|
$-114.33M |
|
$-114.33M |
|
$-114.33M |
|
$-114.33M |
|
$-114.33M |
|
$-120.81M |
|
$-118.31M |
|
103.50M |
|
103.50M |
|
$-1.10 |
|
$-1.10 |
|
| Balance Sheet Financials | |
$551.39M |
|
$25.12M |
|
|
Long-Term Assets |
$434.77M |
$986.16M |
|
$112.59M |
|
-- |
|
$93.65M |
|
$206.24M |
|
$779.92M |
|
$779.92M |
|
$779.92M |
|
103.54M |
|
| Cash Flow Statement Financials | |
$-148.93M |
|
$94.33M |
|
-- |
|
$202.79M |
|
$148.19M |
|
$-54.60M |
|
$21.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.90 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-726.57% |
|
-726.57% |
|
-- |
|
-687.61% |
|
-687.61% |
|
$-149.66M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
1.58 |
|
56.86 |
|
-14.66% |
|
-14.66% |
|
-11.59% |
|
-14.66% |
|
$7.53 |
|
$-1.45 |
|
$-1.44 |
|